Vaccine for COVID-19
India’s COVID-19 strategy: A story of missteps

India has third highest number of COVID-19 cases in the world and is recording close to or over 50,000 cases a day. What explains this relentless surge in cases in the country?

COVID-19 vaccine may come, but what about equitable distribution?

With rich countries and big pharma companies getting proactive, there is widespread apprehension about access and price of the vaccine for countries that need it most.

US quitting WHO will hit global responses to pandemics, vaccine development

Newsclick’s Prabir Purkayastha talks about the US decision to leave the World Health Organization. He points out that this is yet another instance of US exceptionalism and describes how the country iis one of the largest beneficiaries of WHO’s vaccine program.

US Buys Up Remdesivir: We Must Break Patents for Access to COVID-19 Drug

Newsclick’s Prabir Purkayastha discusses the US buying out supplies of the COVID-19 drug, Remdesivir.

COVID-19: Dexamethasone provides some hope for severely ill

In a trial, Dexamethasone, an inexpensive and widely used corticosteroid, reduced deaths by one-third in ventilated patients and by one-fifth in patients receiving oxygen support

Vaccines will be the true game changers, says Dr. Satyajit Rath

Dr. Satyajit Rath talks about how vaccines are essential to turn the tide against the COVID-19 pandemic

US declares vaccine war on the world

What prevents any country from making drugs and vaccines, once developed? Is it the threat of the US, or the belief that in the US-China vaccine war, they need to be on the US side?

COVID-19 and the race for the vaccine

Newsclick’s Prabir Purkayastha and Dr. Satyajit Rath discuss the latest in the research to develop the vaccine for COVID-19.

    × To Subscribe